SILK Longevity is a company that generates various omics data through sequencing and build artificial intelligence platform for healthcare. Our work is guided by our mission to advance our understanding of biology and accelerate the coming of personalized health solutions for individuals, groups and population. Our ultimate goal is to enhance the quality of life through data-driven insights using AI and create a healthier, more sustainable society worldwide.
Our team is led by Minho Shong, M.D. and Ph.D., Professor at the Korea Advanced Institute of Science and Technology in Korea and Adil Mardinoglu, Ph.D., CEO of SZA Longevity and Professor at KTH-Royal Institute of Technology in Sweden and King's College London.
Our team is advised by over 20 Scientific Advisors for research, and we partner closely with SZA Longevity to bring our technology closer to both clinicians and anyone with or without previous knowledge in genetics or systems biology through the app.
